$169.54 $2.70 (1.6%)

04:00 PM EDT on 08/21/19

GALAPAGOS NV (NASDAQ:GLPG)

CAPS Rating: 4 out of 5

Current Price $169.54 Mkt Cap $9.4B
Open $170.06 P/E Ratio 0.00
Prev. Close $166.84 Div. (Yield) $0.00 (0.0%)
Daily Range $169.08 - $170.64 Volume 89,666
52-Wk Range $89.45 - $191.63 Avg. Daily Vol. 9

Caps

How do you think NASDAQ:GLPG will perform against the market?

Add Stock to CAPS Watchlist

All Players

40 Outperform
1 Underperform
 

All-Star Players

19 Outperform
0 Underperform
 

Wall Street

1 Outperform
0 Underperform
 

Top NASDAQ:GLPG Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

sk2129 (32.44)
Submitted September 21, 2015

baker bros

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

NASDAQ:GLPG VS S&P 500 (SPY)

NASDAQ:GLPG Summary

Fools bullish on NASDAQ:GLPG are also bullish on:

Fools bearish on NASDAQ:GLPG are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about GLPG.

Recs

0
Member Avatar ptgrasshopper (< 20) Submitted: 7/23/2018 11:50:12 PM : Outperform Start Price: $108.69 NASDAQ:GLPG Score: +52.22

Large pipeline .

Recs

0
Member Avatar TMFEBCapital (88.01) Submitted: 4/6/2018 12:43:43 PM : Outperform Start Price: $95.78 NASDAQ:GLPG Score: +65.80

Top-line data from its first RA trial with Gilead is anticipated in the second-half of 2018. Data from its triplet in cystic fibrosis with AbbVie is also on tap soon.

Recs

0
Member Avatar Omnius78 (< 20) Submitted: 7/14/2016 1:23:28 PM : Outperform Start Price: $53.44 NASDAQ:GLPG Score: +181.69

Huge potential when Filgotinib gets approved.

Leaderboard

Find the members with the highest scoring picks in GLPG.

Score Leader

RonaldSpeth1

RonaldSpeth1 (51.90) Score: +234.55

The Score Leader is the player with the highest score across all their picks in GLPG.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
RonaldSpeth1 51.90 4/27/2016 Outperform 5Y $45.21 +275.01% +40.45% +234.55 0 Comment
mdn11 68.72 9/28/2015 Outperform 3Y $46.38 +265.55% +52.47% +213.07 0 Comment
A1phaWolf 22.41 2/5/2016 Outperform 3Y $46.69 +263.12% +53.10% +210.02 0 Comment
RayHam0987 < 20 12/7/2015 Outperform 5Y $48.52 +249.42% +39.76% +209.67 0 Comment
efarev 98.55 9/25/2015 Outperform 5Y $47.72 +255.28% +50.67% +204.61 0 Comment
Omnius78 < 20 7/14/2016 Outperform 3Y $53.44 +217.25% +35.56% +181.69 1 Comment
portefeuille4 99.51 9/2/2016 Outperform 5Y $54.24 +212.57% +34.08% +178.50 0 Comment
portefeuille6 99.54 9/2/2016 Outperform 5Y $54.31 +212.17% +34.06% +178.11 0 Comment
portefeuille3 96.89 9/2/2016 Outperform 5Y $54.58 +210.63% +33.78% +176.85 0 Comment
TruffelPig < 20 1/22/2016 Outperform 5Y $53.36 +217.73% +54.08% +163.65 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackStifel 91.40 8/11/2017 Outperform NS $82.34 +105.90% +19.83% +86.07 0 Comment